CN1622813A - 治疗和二级预防深静脉血栓患者静脉血栓栓塞用的药物I draparinux (San0rg 34006) - Google Patents

治疗和二级预防深静脉血栓患者静脉血栓栓塞用的药物I draparinux (San0rg 34006) Download PDF

Info

Publication number
CN1622813A
CN1622813A CNA038028123A CN03802812A CN1622813A CN 1622813 A CN1622813 A CN 1622813A CN A038028123 A CNA038028123 A CN A038028123A CN 03802812 A CN03802812 A CN 03802812A CN 1622813 A CN1622813 A CN 1622813A
Authority
CN
China
Prior art keywords
oxygen
treatment
methyl
sanorg
sulfo group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038028123A
Other languages
English (en)
Chinese (zh)
Inventor
R·G·M·范阿姆斯特丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of CN1622813A publication Critical patent/CN1622813A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CNA038028123A 2002-01-29 2003-01-23 治疗和二级预防深静脉血栓患者静脉血栓栓塞用的药物I draparinux (San0rg 34006) Pending CN1622813A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP002075374.5 2002-01-29
EP02075374 2002-01-29

Publications (1)

Publication Number Publication Date
CN1622813A true CN1622813A (zh) 2005-06-01

Family

ID=27635850

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038028123A Pending CN1622813A (zh) 2002-01-29 2003-01-23 治疗和二级预防深静脉血栓患者静脉血栓栓塞用的药物I draparinux (San0rg 34006)

Country Status (22)

Country Link
US (1) US7709463B2 (enExample)
EP (1) EP1471924B1 (enExample)
JP (1) JP4870907B2 (enExample)
CN (1) CN1622813A (enExample)
AR (1) AR038320A1 (enExample)
AT (1) ATE323497T1 (enExample)
AU (1) AU2003205664B2 (enExample)
BR (1) BR0307196A (enExample)
CA (1) CA2472957C (enExample)
CY (1) CY1107661T1 (enExample)
DE (1) DE60304678T2 (enExample)
DK (1) DK1471924T3 (enExample)
EA (1) EA007204B1 (enExample)
ES (1) ES2262971T3 (enExample)
MX (1) MXPA04007310A (enExample)
NO (1) NO332699B1 (enExample)
PE (1) PE20030855A1 (enExample)
PL (1) PL207144B1 (enExample)
PT (1) PT1471924E (enExample)
SI (1) SI1471924T1 (enExample)
TW (1) TWI281861B (enExample)
WO (1) WO2003063881A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521903A (ja) * 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US9642822B2 (en) 2011-05-27 2017-05-09 Children's Medical Center Corporation Methods for treating and preventing neutrophil-derived net toxicity and thrombosis
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type

Also Published As

Publication number Publication date
NO20043195L (no) 2004-10-29
US20050209175A1 (en) 2005-09-22
EA200400817A1 (ru) 2005-02-24
EA007204B1 (ru) 2006-08-25
PT1471924E (pt) 2006-09-29
TWI281861B (en) 2007-06-01
CA2472957A1 (en) 2003-08-07
CY1107661T1 (el) 2013-04-18
MXPA04007310A (es) 2004-10-29
EP1471924A1 (en) 2004-11-03
DE60304678D1 (de) 2006-05-24
PL370557A1 (en) 2005-05-30
ATE323497T1 (de) 2006-05-15
CA2472957C (en) 2011-09-13
HK1072361A1 (en) 2005-08-26
WO2003063881A1 (en) 2003-08-07
US7709463B2 (en) 2010-05-04
BR0307196A (pt) 2004-11-03
AR038320A1 (es) 2005-01-12
ES2262971T3 (es) 2006-12-01
PL207144B1 (pl) 2010-11-30
AU2003205664B2 (en) 2008-06-05
SI1471924T1 (sl) 2006-10-31
PE20030855A1 (es) 2003-10-11
DE60304678T2 (de) 2007-04-05
EP1471924B1 (en) 2006-04-19
DK1471924T3 (da) 2006-08-21
NO332699B1 (no) 2012-12-10
JP4870907B2 (ja) 2012-02-08
JP2005519919A (ja) 2005-07-07
TW200302104A (en) 2003-08-01

Similar Documents

Publication Publication Date Title
JP7298818B2 (ja) 低ナトリウムポロキサマー188製剤および使用方法
CN1688306A (zh) 泊沙康唑用于治疗真菌感染的用途
TW201818946A (zh) 包含至少一種氧化膽固醇硫酸鹽及至少一種聚烯烴二醇、羧甲基纖維素及聚氧甘油酯之組成物及彼等之使用方法
CN1170533C (zh) 用于肠胃外给药的药学上稳定的奥沙利铂制剂
CN1378472A (zh) 通过低分子量肝素与血小板聚集抑制剂间协同作用防治各种血栓栓塞疾病的联合治疗方法
KR20080110755A (ko) 항암 용도를 위한 독소루비신 제형
JP6869255B2 (ja) 凍結医薬製剤およびその使用
CN1622813A (zh) 治疗和二级预防深静脉血栓患者静脉血栓栓塞用的药物I draparinux (San0rg 34006)
CN1291718C (zh) 一种用于治疗急性心肌梗死的药物产品
CN1627948A (zh) 治疗炎症性肠病的组合物和试剂盒
EP2063909B1 (en) Formulations for therapeutic administration of thyroid stimulating hormone (TSH)
Zucker et al. Chemotherapy of tuberculosis: promin by the intravenous drip method
CN1602197A (zh) 特定剂量的Fondaparinux Sodi um在治疗急性冠状动脉综合征中的应用
AU2003205664A1 (en) Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
JPWO2020092523A5 (enExample)
CN1064234C (zh) 二咖啡酰氧基--奎宁酸在制药中的应用
WO2022199551A1 (en) Dc009 for treating acute ischemic stroke
WO2023102690A1 (en) Oral delivery of heparins
CN107174589B (zh) 氢氧化铝在制备防治肝纤维化药物中的应用
CN101277693A (zh) 依诺肝素在实施经皮冠状动脉介入治疗中的应用
JP2001354572A (ja) 肝疾患処置剤
HK1072361B (en) Idraparinux (sanorg 34006) for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis
CA3178926A1 (en) Synergistic anti-viral pharmaceutical composition containing targeting nanoparticles
CN1850097A (zh) 灯盏花乙素注射制剂及其制备方法
JPWO2023095000A5 (enExample)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication